[ET Net News Agency, 17 September 2021] HEPALINK (09989) fell 1.94% to HK$8.59.
It hits an intra-day low of HK$8.59, hitting a historical low, and an intra-day high of
HK$8.79. The total shares traded was 235,184, with a value of HK$2.04m. The active
buy/sell ratio is 38:62, with net selling turnover of HK$483,125. FUTU SEC INT'L accounts
for greatest net responsive buying turnover of HK$213,750, with volume weighted average
price of HK$8.752. CREDIT SUISSE (HK) SEC accounts for greatest net responsive selling
turnover of HK$344,140, with volume weighted average price of HK$8.658. The stock has
fallen a combined 7.14% over the past 5 consecutive trading days.
The Hang Seng Index now rose 165 points, or 0.67% to 24,833; the Hang Seng China
Enterprises Index now rose 98 points, or 1.11% to 8,903; the Hang Seng TECH Index now rose
186 points, or 3% to 6,419; with an overall turnover of HK$122.68b.
The SSE Composite Index now rose 6 points, or 0.19% to 3,613, with an overall turnover
of RMB628.83b.
The SZSE Component Index now rose 101 points, or 0.71% to 14,359, with an overall
turnover of RMB334.1b.
Basic Information
-------------------------------------------
Nominal 8.590 % Chg -1.94%
High 8.790 Low 8.590
Shares Tr 235,184 Turnover 2.04m
10-D SMA 9.028 %H.V 26.547
20-D SMA 9.040 VWAP 8.659
50-D SMA 9.458 RSI14 32.008
-------------------------------------------
Status: Hitting a historical low, active buy/sell ratio is 38:62, with net selling
turnover of HK$483,125, falling a combined 7.14% over the past 5 consecutive
trading days
Table: Performance of stocks in the same sector or of relevance
Stock (Code) Price(HK$) Change(%)
-------------------------------------------------
HEPALINK (09989) 8.59 -1.94
SIHUAN PHARM (00460) 2.11 +6.03
CMS (00867) 14.94 +3.32
CSPC PHARMA (01093) 9.61 +4.68
SINO BIOPHARM (01177) 6.32 +0.80
3SBIO (01530) 8.28 +2.48
FOSUN PHARMA (02196) 45.75 +2.81
WUXI APPTEC (02359) 176.90 +4.06
HANSOH PHARMA (03692) 20.30 +5.18
PHARMARON (03759) 184.50 +3.89
-------------------------------------------------
(ed)